The importance of tetanus risk assessment during wound management  by Collins, Sarah et al.
IDCases 2 (2015) 3–5Case Report
The importance of tetanus risk assessment during wound
management
Sarah Collins *, Joanne White, Mary Ramsay, Gayatri Amirthalingam
Immunisation, Hepatitis, & Blood Safety Department (IHBSD), Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England,
61 Colindale Avenue, London NW9 5EQ, UK
A R T I C L E I N F O
Article history:
Received 29 October 2014
Received in revised form 19 November 2014
Accepted 22 November 2014
Keywords:
Tetanus
Immunization
Prophylaxis
Wound management
A B S T R A C T
Public Health England undertakes surveillance of vaccine preventable diseases including enhanced
surveillance of clinically suspected tetanus. In the United Kingdom, tetanus has become increasingly rare
due to the success of the national routine immunization program. Consequently, few practitioners have
experience of diagnosing and managing patients with clinical tetanus. We report two cases of tetanus
where comparatively minor wounds proved fatal. These cases highlight the importance of the accurate
identiﬁcation and management of tetanus prone wounds and the fatal consequences from untreated
injuries in susceptible individuals. We conclude that appropriate risk assessment for tetanus prophylaxis
forms an essential part of wound management.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Tetanus is a potentially life threatening disease which is caused
by a neurotoxin produced following germination of spores of
Clostridium tetani which are ubiquitous in the environment
[1]. Tetanus is acquired by the inoculation of a wound with
tetanus spores. Public Health England (PHE) undertakes surveil-
lance of vaccine preventable diseases including enhanced surveil-
lance of clinically suspected tetanus; all suspected cases are
followed up with the patient’s general practitioner to ascertain
demographic and clinical information, vaccination history, and risk
factors. Here we report on two cases of tetanus where compara-
tively minor wounds proved fatal.
Case 1
A 91-year old woman attended Accident and Emergency after
sustaining a laceration to her head while gardening. The head
wound was sutured and she was discharged without receiving
tetanus prophylaxis. Six days later she was admitted to hospital
with facial paralysis, spasticity, and trismus; a clinical diagnosis of
tetanus was considered, reported to the local health protection
team and serum and a head wound swab were sent to the PHE
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4.0/).(RVPBRU). Despite receiving a treatment dose of immunoglobulin,
her clinical condition deteriorated and she died the next day.
Serological testing conﬁrmed that she did not have protective
levels of tetanus antibodies (0.058 IU/mL), supporting a diagnosis
of clinical tetanus. C. tetani neurotoxin genes were detected by PCR
conﬁrming the presence of the organism in the wound. Tetanus
was recorded as the cause of death. Routine PHE follow up of the
case identiﬁed she was unimmunized.
Case 2
An 82-year old woman fell in her garden resulting in an
abrasion to her arm which became infected. She did not seek
medical advice at the time of the injury. Eight days later she was
complaining of dysphagia and was assessed at home by her general
practitioner. On review the next day she was referred to Accident
and Emergency with neck stiffness and an inability to open her
mouth. Tetanus was not initially considered as part of the different
diagnosis; she was prescribed simple analgesia and discharged the
same day. Due to a marked deterioration in her clinical condition
she was readmitted the following day with trismus, spasticity and
spasms; a serum sample was taken and the case reported to the
local health protection team. Following surgical debridement of
her wound, she was transferred to intensive care with suspected
clinical tetanus, started on broad spectrum antibiotics and given a
treatment dose of human normal immunoglobulin (HNIG) [2]. The
patient was unimmunized and refused tetanus vaccination whilst
in hospital. Serological testing conﬁrmed she did not havee under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
S. Collins et al. / IDCases 2 (2015) 3–54protective levels of tetanus speciﬁc antibodies (0.076 IU/mL).
Nineteen days after the initial injury, she died in intensive care
from acute tetanus.
Discussion
Tetanus is a potentially fatal vaccine preventable infection
caused by a neurotoxin which is produced by C. tetani [1]. Cases of
clinical tetanus are becoming increasingly rare in the UK due to the
success of the vaccination program and many practitioners are
unlikely to have had ﬁrst hand experience of managing such
patients. Tetanus prone wounds, including those classed as high
risk, however, are a comparatively common presentation to
Accident and Emergency departments [3]. These two cases
highlight risks associated with delays in recognition of tetanus
prone wounds and the fatal consequences from untreated injuries
in susceptible individuals.
In the UK, armed forces personnel have been immunized
against tetanus since 1938 with tetanus vaccination incorporated
into the childhood immunization schedule from 1961 [2]. The
current UK schedule comprises of ﬁve doses of tetanus-containing
vaccine commencing with a primary course at two, three and four
months of age, with booster doses offered pre-school (around three
years four months) and during adolescence (between 13 and
18 years old) [4]. Coverage of tetanus vaccination evaluated at two
years of age has been at least 94% for the last 20 years;
seroprevalence data from 2009 suggested that 83% of the
population were protected against tetanus although 36% of
individuals aged over 70 were found to be susceptible, with
women having signiﬁcantly lower antibody levels than men
[5,6]. Most cases of tetanus occurred in susceptible individuals
who were either unimmunized or partially immunized and did not
have protective levels of antibodies at the time of exposure to C.
tetani [7,8]. Adults born prior to 1961, who are more likely to have
missed out on childhood vaccinations, are over-represented in this
population [6,9]. Sporadic clusters of tetanus in the UK have also
been reported among people who inject drugs (PWID) [10].
National guidance on tetanus vaccination and post-exposure
prophylaxis classify the following types of wound as tetanus prone [2]:
 wounds or burns that require surgical intervention that is
delayed for more than 6 h;
 wounds or burns that show a signiﬁcant degree of devitalized
tissue or a puncture-type injury, including animal bites,
particularly where there has been contact with soil or manure;
 wounds containing foreign bodies;
 compound fractures;
 wounds or burns in patients who have systemic sepsis.Table 1
Prophylaxis with tetanus toxoid containing vaccine and human tetanus immunoglobu
Immunisation status Clean wound 
Fully immunised (ﬁve doses of vaccine given at
appropriate intervals)
No vaccination required. 
Primary immunisation complete, boosters up to
date but incomplete
Vaccinate if next dose du
Primary immunisation not complete or boosters
not up to date
Reinforcing dose of vaccin
immediately.
Arrange further vaccinatio
to complete ﬁve dose cou
Not immunised or immunisation status
unknown / uncertain
One dose of vaccine to be
immediately.
Arrange further vaccinatio
to complete ﬁve dose cou
* Adapted from Chapter 30 of the Green book [3].Wounds are considered high risk if heavily contaminated with
material likely to contain tetanus spores.
During 2006–2013, PHE surveillance data [7] recorded 44 cases
of clinical tetanus and ﬁve deaths. Cases were aged eight to
91 years old, 54.5% (24/44) were born before 1961; 52% (23/44)
were male, however among those aged over 69 years 64.7% (11/17)
were female. Overall, 84% (31/37) had a recorded injury; 81% of
which were acquired in their home or garden. Three cases in PWID
were recorded [10]. No cases of severe tetanus were observed
during this period in persons who received appropriate post-
exposure prophylaxis. Treatment before the onset of tetanus was
recorded in eight cases, none of whom received prophylaxis
appropriate to their injury and immunization history.
The timely administration of post-exposure prophylaxis
following an injury can prevent clinical tetanus from developing
or lessen the severity of infection [11]. When a person presents
with a wound, their injury should be assessed and thoroughly
cleaned [2]. The type of tetanus prophylaxis recommended
depends on the nature of wound and the patient’s vaccination
history (Table 1). Fully immunized patients who are immuno-
suppressed should be managed as if they are incompletely
immunized [2].
When left untreated, clinical signs of tetanus infection
including muscle rigidity and spasms, usually present between
4 and 21 days after inoculation. The diagnosis of tetanus is
primarily based on clinical features [1] and treatment should not
be delayed until laboratory evidence is available. When tetanus is
suspected a serum sample should be taken prior to the initiation of
prophylactic treatment and sent to an appropriate reference
laboratory, such as the Respiratory and Vaccine Preventable
Bacteria Reference Unit at PHE, for immunity testing [12]. Antibody
levels below 0.1 IU/mL (the putative protective level) are consis-
tent with tetanus. Treatment delays allow additional tetanus
neurotoxin to bind to the peripheral and central nervous system,
increasing the severity of disease. Management should include the
administration of tetanus immunoglobulin (TIG), wound debride-
ment, antimicrobial agents active against anaerobes, and vaccina-
tion with tetanus toxoid upon recovery. In severe cases of tetanus
(grade 3) specialist care including respiratory support may be
required. If TIG is not available then HNIG may be used [13].
It is important to note that recovery from tetanus does not
confer immunity [2]. Therefore, patients with clinical tetanus will
still require appropriate vaccination to provide protection against
subsequent exposures.
Most patients presenting with tetanus prone wounds are seen
either by their general practitioner or at Accident and Emergency
departments. A recent review of tetanus prophylaxis among
staff in Accident and Emergency departments found variations in
self-reported level of knowledge and practice; only a third oflin (Tig) according to vaccination status and wound type*.
Tetanus prone / high risk wound
Give Tig if high risk.
No vaccination required.
e. Give Tig if high risk.
Vaccinate if next dose due.
e given
n as required
rse.
Give Tig and a reinforcing dose of vaccine at different sites.
Arrange further vaccination as required to complete ﬁve
dose course.
 given
n as required
rse.
Give Tig and a reinforcing dose of vaccine at different sites.
Arrange further vaccination as required to complete ﬁve
dose course.
S. Collins et al. / IDCases 2 (2015) 3–5 5respondents who had local guidelines available said they were
always followed [14]. These gaps in knowledge and lack of
adherence to current national guidance can lead to patients
receiving inadequate care. Similar ﬁnding have been observed in
the United States and Europe [15,16]. Clear local commissioning
pathways are essential to ensure the provision of timely post
exposure prophylaxis for vaccine preventable infections such as
tetanus. Whenever possible Accident and Emergency departments
should provide a ﬁrst dose of tetanus containing vaccine to
patients with an incomplete or uncertain immunization history as
patients referred back to general practice may not attend. Clear and
effective guidance for the provision of tetanus prophylaxis is
readily available [2]. Local and national public health practitioners
provide a source of expert advice on appropriate prophylaxis,
laboratory tests, and treatment of tetanus. Immunization history is
required for the appropriate risk assessment of patients presenting
with wounds. Many patients, especially among the elderly, may
not be aware of their immunization status nor have it recorded
adequately in their health records and are may therefore be
incorrectly assumed to be fully vaccinated. In the UK, patients born
before 1961 would not have been eligible for routine immuniza-
tion, although some men would have been immunized during
national service, and may have incomplete vaccination histories.
Ensuring wounds are managed in accordance with national
guidelines and appropriate immunization delivered to susceptible
patients requires effective communication between the primary
and secondary care. Tetanus is a statutory notiﬁable disease and
the local health protection team must be informed of suspected
cases.
The simple cost-effective intervention of taking the time to
investigate a patient’s vaccination history and provide timely
prophylaxis, particularly to patients who are not known to be fully
immunized, can prevent individuals from developing this life-
threatening illness.
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